BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 481.60K | 473.20K | 472.70K | 471.90K | 472.20K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 481.60K | 473.20K | 472.70K | 471.90K | 472.20K |
Operating Income | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
Income Before Tax | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.48 | -0.47 | -0.47 | -0.47 | -0.47 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
EBIT | -481.60K | -473.20K | -472.70K | -471.90K | -472.20K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Average Basic Shares Outstanding | 117.09M | 117.09M | 117.09M | 117.09M | 117.09M |
Average Diluted Shares Outstanding | 117.09M | 117.09M | 117.09M | 117.09M | 117.09M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |